| Hal J Bashein, DO | |
|
2051 45th St, Suite 203, West Palm Beach, FL 33407-2027 | |
| (561) 848-8700 | |
| (561) 848-7070 |
| Full Name | Hal J Bashein |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 32 Years |
| Location | 2051 45th St, West Palm Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306818083 | NPI | - | NPPES |
| 204650 | Other | FL | AVMED |
| P03512 | Other | FL | FREEDOM |
| 0642985 | Other | FL | CIGNA |
| 370525100 | Medicaid | FL | |
| 4404227 | Other | FL | AETNA |
| P01649227 | Other | FL | RR MEDICARE |
| 80572 | Other | FL | BCBS |
| P971487 | Other | FL | OPTIMUM |
| 1241662 | Other | FL | WELLCARE |
| 3437 | Other | FL | DIMENSION |
| 1010099 | Other | FL | CAREPLUS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | OS 6143 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jfk Medical Center | Atlantis, FL | Hospital |
| Good Samaritan Medical Center | West palm beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesiscare Usa Of Florida Llc | 9830082882 | 263 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced results of the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) 10-Year Follow-up Study at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston. The study demonstrated implantable cardioverter defibrillator (ICD) therapy significantly reduces mortality for at least 11 years in patients with moderate heart failure (HF).
Scanning a premature infant's brain shortly after birth to map the location and volume of lesions, small areas of injury in the brain's white matter, may help doctors better predict whether the baby will have disabilities later, according to a new study published in the January 18, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Dendreon Corporation, a Seattle-based biotechnology company, will implement Pilgrim's automated system for Deviation and Corrective and Preventive Action (CAPA) management using its on-demand software as a service platform.
In a large clinical trial, nilotinib demonstrated greater efficacy over the current gold standard treatment, imatinib, in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in the chronic phase.
Although there is widespread consensus among the scientific community that the composition of generic drugs is identical to that of brand name drugs, this is not the case among the public.
› Verified 4 days ago
| Entity Name | Genesiscare Usa Of Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134109747 PECOS PAC ID: 9830082882 Enrollment ID: O20040204000663 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced results of the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) 10-Year Follow-up Study at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston. The study demonstrated implantable cardioverter defibrillator (ICD) therapy significantly reduces mortality for at least 11 years in patients with moderate heart failure (HF).
Scanning a premature infant's brain shortly after birth to map the location and volume of lesions, small areas of injury in the brain's white matter, may help doctors better predict whether the baby will have disabilities later, according to a new study published in the January 18, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Dendreon Corporation, a Seattle-based biotechnology company, will implement Pilgrim's automated system for Deviation and Corrective and Preventive Action (CAPA) management using its on-demand software as a service platform.
In a large clinical trial, nilotinib demonstrated greater efficacy over the current gold standard treatment, imatinib, in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in the chronic phase.
Although there is widespread consensus among the scientific community that the composition of generic drugs is identical to that of brand name drugs, this is not the case among the public.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hal J Bashein, DO 2234 Colonial Blvd, Attn: Payer Contracting & Relations Dept., Fort Myers, FL 33907-1412 Ph: (239) 931-7342 | Hal J Bashein, DO 2051 45th St, Suite 203, West Palm Beach, FL 33407-2027 Ph: (561) 848-8700 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced results of the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) 10-Year Follow-up Study at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston. The study demonstrated implantable cardioverter defibrillator (ICD) therapy significantly reduces mortality for at least 11 years in patients with moderate heart failure (HF).
Scanning a premature infant's brain shortly after birth to map the location and volume of lesions, small areas of injury in the brain's white matter, may help doctors better predict whether the baby will have disabilities later, according to a new study published in the January 18, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Dendreon Corporation, a Seattle-based biotechnology company, will implement Pilgrim's automated system for Deviation and Corrective and Preventive Action (CAPA) management using its on-demand software as a service platform.
In a large clinical trial, nilotinib demonstrated greater efficacy over the current gold standard treatment, imatinib, in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in the chronic phase.
Although there is widespread consensus among the scientific community that the composition of generic drugs is identical to that of brand name drugs, this is not the case among the public.
› Verified 4 days ago
Dr. John Robert Stripling Iii, M.D. Urology Medicare: Medicare Enrolled Practice Location: 7606 Pine Tree Ln, West Palm Beach, FL 33406 Phone: 404-433-6960 Fax: 561-538-8420 | |
Dr. William Harry Gans, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 525 Okeechobee Blvd, Suite 1400, West Palm Beach, FL 33401 Phone: 561-804-0200 Fax: 561-804-0222 | |
Joseph Vincent D'angelo, M D Urology Medicare: Not Enrolled in Medicare Practice Location: 1411 N Flagler Dr, Suite 6800, West Palm Beach, FL 33401 Phone: 561-832-0183 Fax: 561-863-6999 | |
Dr. Murray Glenn Goldberg, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1411 N Flagler Dr, Suite 5300, West Palm Beach, FL 33401 Phone: 561-833-5594 Fax: 561-833-0017 | |
Alan J Wein, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 185 Banyan Blvd Ste 200, West Palm Beach, FL 33401 Phone: 561-219-2424 | |
Nycole I Veloza, APRN Urology Medicare: Medicare Enrolled Practice Location: 770 Northpoint Pkwy Ste 102, West Palm Beach, FL 33407 Phone: 561-655-3331 |